Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial

Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial

Abstract Background It is widely acknowledged that HPV prophylactic vaccine could prevent new infections and their associated lesions among women who are predominantly HPV-naive at vaccination. Yet there still remains uncertainty about whether HPV vaccination could benefit to individuals who have un...

Full description

Bibliographic Details
Main Authors: Shuang Zhao, Shangying Hu, Xiaoqian Xu, Xun Zhang, Qinjing Pan, Feng Chen, Fanghui Zhao
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Infectious Diseases
Subjects:
Human papillomavirus
Cervical Cancer
Excision treatment
Clinical trial
Vaccine
Online Access:http://link.springer.com/article/10.1186/s12879-020-05560-z

Internet

http://link.springer.com/article/10.1186/s12879-020-05560-z

Similar Items